Dr. Davidson on Screening for Ovarian Cancer

Video

Dr. Nancy Davidson, from the University of Pittsburgh Cancer Institute, on Screening for Ovarian Cancer

Nancy E. Davidson, MD, director, University of Pittsburgh Cancer Institute and UPMC Cancer Centers, discusses two methods of screening for ovarian cancer, which have both been proven to be ineffective.

The two primary methods of screening for ovarian cancer include a CA-125 blood test and transvaginal ultrasound. These methods have been studied in several large international trials in women at risk for developing ovarian cancer. Overwhelmingly they found that although these methods were able to find some cancers the number of false positives and needless surgeries outweighed their potential benefits.

Davidson notes that it is important to always practice evidence-based medicine; this includes the need to weigh potential benefits with risks for any procedure. Physicians should discuss the risks with their patients while noting that in some cases, for patients at high-risk, these screening procedures may still be valuable.

Related Videos
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD
Wenxin (Vincent) Xu, MD,
Guenther Koehne, MD, PhD
Alessandro Villa, DDS, PhD, MPH
Joseph Mikhael, MD
Michael Richardson, MD
Minesh Mehta, MD
Ruben Olivares, MD
Phillip J. Koo, MD